Ancrod versus heparin for anticoagulation during vascular surgical procedures
- 1 February 1993
- journal article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 17 (2) , 288-293
- https://doi.org/10.1016/0741-5214(93)90414-h
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Ancrod Causes Rapid Thrombolysis in Patients with Acute StrokeThe Lancet Healthy Longevity, 1990
- Ancrod (Arvin®) as an Alternative to Heparin Anticoagulation for Cardiopulmonary BypassAnesthesiology, 1989
- Use of ancrod in acute or progressing ischemic cerebral infarctionAnnals of Emergency Medicine, 1988
- Effect of defibrinogenation on the early patency rate of experimental small calibre arterial graftsBritish Journal of Surgery, 1987
- Controlled Trial of Ancrod in Ischemic StrokeArchives of Neurology, 1983
- CONTROLLED TRIAL OF ANCROD AND HEPARIN IN TREATMENT OF DEEP-VEIN THROMBOSIS OF LOWER LIMBThe Lancet, 1972
- Blood Fibrinolytic Activity during Arvin TherapyBritish Journal of Haematology, 1969
- THERAPEUTIC DEFIBRINATION IN THE TREATMENT OF THROMBOTIC DISEASEThe Lancet, 1968
- The Isolation and Properties of the Thrombin‐like Activity from Ancistrodon rhodostoma VenomBritish Journal of Haematology, 1967
- Actions of Some Coagulant Snake Venoms on Blood PlateletsNature, 1965